South Korea · Delayed Price · Currency is KRW Genic Statistics
Total Valuation
Genic has a market cap or net worth of KRW 249.61 billion. The enterprise value is 251.45 billion.
| Market Cap | 249.61B |
| Enterprise Value | 251.45B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genic has 7.82 million shares outstanding. The number of shares has increased by 0.48% in one year.
| Current Share Class | 7.82M |
| Shares Outstanding | 7.82M |
| Shares Change (YoY) | +0.48% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 5.44% |
| Float | 4.72M |
Valuation Ratios
The trailing PE ratio is 9.58.
| PE Ratio | 9.58 |
| Forward PE | n/a |
| PS Ratio | 2.18 |
| PB Ratio | 4.47 |
| P/TBV Ratio | 4.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 39.35 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 9.65 |
| EV / Sales | 2.20 |
| EV / EBITDA | 11.56 |
| EV / EBIT | 13.13 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.83 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.26 |
| Debt / FCF | -6.17 |
| Interest Coverage | 58.19 |
Financial Efficiency
Return on equity (ROE) is 61.02% and return on invested capital (ROIC) is 38.50%.
| Return on Equity (ROE) | 61.02% |
| Return on Assets (ROA) | 16.98% |
| Return on Invested Capital (ROIC) | 38.50% |
| Return on Capital Employed (ROCE) | 32.95% |
| Weighted Average Cost of Capital (WACC) | 6.41% |
| Revenue Per Employee | 352.74M |
| Profits Per Employee | 80.44M |
| Employee Count | 324 |
| Asset Turnover | 1.62 |
| Inventory Turnover | 6.00 |
Taxes
| Income Tax | -6.87B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.02% in the last 52 weeks. The beta is 0.40, so Genic's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +18.02% |
| 50-Day Moving Average | 27,334.00 |
| 200-Day Moving Average | 23,419.60 |
| Relative Strength Index (RSI) | 57.69 |
| Average Volume (20 Days) | 364,233 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genic had revenue of KRW 114.29 billion and earned 26.06 billion in profits. Earnings per share was 3,331.10.
| Revenue | 114.29B |
| Gross Profit | 27.91B |
| Operating Income | 19.15B |
| Pretax Income | 19.19B |
| Net Income | 26.06B |
| EBITDA | 21.75B |
| EBIT | 19.15B |
| Earnings Per Share (EPS) | 3,331.10 |
Balance Sheet
The company has 3.77 billion in cash and 5.60 billion in debt, with a net cash position of -1.84 billion or -234.92 per share.
| Cash & Cash Equivalents | 3.77B |
| Total Debt | 5.60B |
| Net Cash | -1.84B |
| Net Cash Per Share | -234.92 |
| Equity (Book Value) | 55.79B |
| Book Value Per Share | 7,128.67 |
| Working Capital | 27.16B |
Cash Flow
In the last 12 months, operating cash flow was 6.34 billion and capital expenditures -7.25 billion, giving a free cash flow of -907.47 million.
| Operating Cash Flow | 6.34B |
| Capital Expenditures | -7.25B |
| Depreciation & Amortization | 2.60B |
| Net Borrowing | -2.40B |
| Free Cash Flow | -907.47M |
| FCF Per Share | -115.98 |
Margins
Gross margin is 24.42%, with operating and profit margins of 16.76% and 22.80%.
| Gross Margin | 24.42% |
| Operating Margin | 16.76% |
| Pretax Margin | 16.79% |
| Profit Margin | 22.80% |
| EBITDA Margin | 19.03% |
| EBIT Margin | 16.76% |
| FCF Margin | n/a |
Dividends & Yields
Genic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.48% |
| Shareholder Yield | -0.48% |
| Earnings Yield | 10.44% |
| FCF Yield | -0.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.0103113.
| Last Split Date | Dec 27, 2017 |
| Split Type | Forward |
| Split Ratio | 1.0103113 |
Scores
Genic has an Altman Z-Score of 6.05 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.05 |
| Piotroski F-Score | 4 |